Norwegian

Norwegian Antibodies is a specialized biotechnology company focused on the production of high-quality polyclonal antibodies, specifically avian Immunoglobulin Y (IgY) derived from chicken egg yolks. The company provides custom antibody production services and a catalog of secondary antibodies for use in diagnostic assays, research, and therapeutic development. By utilizing IgY technology, Norwegian Antibodies offers a more ethical and efficient alternative to traditional mammalian antibody production, benefiting from the high yield and phylogenetic distance of avian hosts. Their services cater to global pharmaceutical, diagnostic, and academic institutions requiring large-scale, consistent antibody supplies.